Pneumonia pathogen detection and microbial interactions in polymicrobial episodes

Future Microbiology

Volumn 8, Issue 5, 2013, Pages 633-660

  Bousbia, Sabri ^a,b   Raoult, Didier ^a,b   La Scola, Bernard ^a,b  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b Pôle Hospitalier de Microbiologie et Maladies Infectieuses   (France)

Author keywords

microbial diagnosis; pneumonia; species interaction

Indexed keywords

ANTIBIOTIC AGENT;

AMOEBA (GENUS); ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CELL CULTURE; CENTRIFUGATION; COCULTURE; DISEASE ASSOCIATION; DNA MICROARRAY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGUS IDENTIFICATION; GRAM STAINING; HUMAN; IMMUNOFLUORESCENCE TEST; INTENSIVE CARE UNIT; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL GROWTH; MICROORGANISM DETECTION; MICROSCOPY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; ORGANISMAL INTERACTION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SECONDARY INFECTION; SENSITIVITY AND SPECIFICITY; SEROLOGY; VENTILATOR ASSOCIATED PNEUMONIA;

BACTERIAL INFECTIONS; COINFECTION; HUMANS; LUNG DISEASES, FUNGAL; MICROBIAL INTERACTIONS; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; PNEUMONIA;

EID: 84877274044     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.26     Document Type: Review

References (204)

1. Vincent JL. Nosocomial infections in adult intensive-care units. Lancet 361(9374), 2068-2077 (2003).
2. Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274(8), 639-644 (1995).
3. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171(4), 388-416 (2005).
4. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 165(7), 867-903 (2002).
5. Alp E, Voss A. Ventilator associated pneumonia and infection control. Ann. Clin. Microbiol. Antimicrob. 5, 7 (2006).
6. Torres A, El-Ebiary M. Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia. Chest 117(4 Suppl. 2), S198-S202 (2000).
7. Bousbia S, Papazian L, Auffray JP et al. Tropheryma whipplei in patients with pneumonia. Emerg. Infect. Dis. 16(2), 258-263 (2010).
8. Kawanami T, Fukuda K, Yatera K et al. Severe pneumonia with Leptotrichia sp. detected predominantly in bronchoalveolar lavage fluid by use of 16S rRNA gene sequencing analysis. J. Clin. Microbiol. 47(2), 496-498 (2009).
9. Bahrani-Mougeot FK, Paster BJ, Coleman S et al. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J. Clin. Microbiol. 45(5), 1588-1593 (2007).
10. Harris JK, De Groote MA, Sagel SD et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc. Natl Acad. Sci. USA 104(51), 20529-20533 (2007).
11. Armougom F, Bittar F, Stremler N et al. Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing. Eur. J. Clin. Microbiol. Infect. Dis. 28(9), 1151-1154 (2009).
12. Bittar F, Richet H, Dubus JC et al. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS ONE 3(8), e2908 (2008).
13. Bousbia S, Papazian L, Saux P et al. Repertoire of intensive care unit pneumonia microbiota. PLoS ONE 7(2), e32486 (2012).
14. Berger P, Papazian L, Drancourt M, La Scola B, Auffray JP, Raoult D. Ameba-associated microorganisms and diagnosis of nosocomial pneumonia. Emerg. Infect. Dis. 12(2), 248-255 (2006).
15. Brunstein JD, Cline CL, McKinney S, Thomas E. Evidence from multiplex molecular assays for complex multipathogen interactions in acute respiratory infections. J. Clin. Microbiol. 46(1), 97-102 (2008).
16. de Roux A, Ewig S, Garcia E et al. Mixed community-acquired pneumonia in hospitalised patients. Eur. Respir. J. 27(4), 795-800 (2006).
17. Brogden KA, Guthmiller JM, Taylor CE. Human polymicrobial infections. Lancet 365(9455), 253-255 (2005).
18. Timsit JF, Cheval C, Gachot B et al. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia. Intensive Care Med. 27(4), 640-647 (2001).
19. Anevlavis S, Petroglou N, Tzavaras A et al. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J. Infect. 59(2), 83-89 (2009).
20. Papazian L, Utillo-Touati A, Thomas P et al. Diagnosis of ventilator-associated pneumonia: an evaluation of direct examination and presence of intracellular organisms. Anesthesiology 87(2), 268-276 (1997).
21. Katayama Y, Minami H, Enomoto M, Takano T, Hayashi S, Lee YK. Usefulness of Gram staining of tracheal aspirates in initial therapy for ventilator-associated pneumonia in extremely preterm neonates. J. Perinatol. 30(4), 270-274 (2010).
22. Ioanas M, Ferrer R, Angrill J, Ferrer M, Torres A. Microbial investigation in ventilator-associated pneumonia. Eur. Respir. J. 17(4), 791-801 (2001).
23. Sirvent JM, Vidaur L, Gonzalez S et al. Microscopic examination of intracellular organisms in protected bronchoalveolar mini-lavage fluid for the diagnosis of ventilator-associated pneumonia. Chest 123(2), 518-523 (2003).
24. Brandão da Silva N, Martins L, Martins F et al. Direct examination and cultures of bronchoalveolar lavage in pneumonia diagnosis: a comparative experimental study. Intensive Care Med. 33(10), 1840-1847 (2007).
25. Allaouchiche B, Jaumain H, Chassard D, Bouletreau P. Gram stain of bronchoalveolar lavage fluid in the early diagnosis of ventilator-associated pneumonia. Br. J. Anaesth. 83(6), 845-849 (1999).
26. Shelton K. Automated gram staining increases reliability and safety. MLO Med. Lab. Obs. 42(6), 44 (2010).
27. Niederman MS. The argument against using quantitative cultures in clinical trials and for the management of ventilator-associated pneumonia. Clin. Infect. Dis. 51(Suppl. 1), S93-S99 (2010).
28. Feeley JC, Gibson RJ, Gorman GW et al. Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila. J. Clin. Microbiol. 10(4), 437-441 (1979).
29. Morton HE, Smith PF, Leberman PR. Investigation of the cultivation of pleuropneumonia-like organisms from man. Am. J. Syph. Gonorrhea. Vener. Dis. 35(4), 361-369 (1951).
30. Adler H, Straub C, Frei R. Comparison of BacT/ALERT 3D, Lowenstein-Jensen medium and Middlebrook 7H10/7H11 biplate for recovering mycobacteria from clinical specimens. Eur. J. Clin. Microbiol. Infect. Dis. 24(7), 499-500 (2005).
31. Mylotte JM, Tayara A. Blood cultures: clinical aspects and controversies. Eur. J. Clin. Microbiol. Infect. Dis. 19(3), 157-163 (2000).
32. Combes A, Figliolini C, Trouillet JL et al. Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest 121(5), 1618-1623 (2002).
33. Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn. Microbiol. Infect. Dis. 59(4), 401-406 (2007).
34. She RC, Thurber A, Hymas WC et al. Limited utility of culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae for diagnosis of respiratory tract infections. J. Clin. Microbiol. 48(9), 3380-3382 (2010).
35. Janda JM, Abbott SL. Bacterial identification for publication: when is enough enough? J. Clin. Microbiol. 40(6), 1887-1891 (2002).
36. Engler HD, Preuss J. Laboratory diagnosis of respiratory virus infections in 24 hours by utilizing shell vial cultures. J. Clin. Microbiol. 35(8), 2165-2167 (1997).
37. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J. Clin. Microbiol. 19(6), 917-919 (1984).
38. Marrero M, Raoult D. Centrifugation-shell vial technique for rapid detection of Mediterranean spotted fever rickettsia in blood culture. Am. J. Trop. Med. Hyg. 40(2), 197-199 (1989).
39. Matthey S, Nicholson D, Ruhs S et al. Rapid detection of respiratory viruses by shell vial culture and direct staining by using pooled and individual monoclonal antibodies. J. Clin. Microbiol. 30(3), 540-544 (1992).
40. Navarro-Mari JM, Sanbonmatsu-Gamez S, Perez-Ruiz M, De La Rosa-Fraile M. Rapid detection of respiratory viruses by shell vial assay using simultaneous culture of HEp-2, LLC-MK2, and MDCK cells in a single vial. J. Clin. Microbiol. 37(7), 2346-2347 (1999).
41. Olsen MA, Shuck KM, Sambol AR, Flor SM, O'Brien J, Cabrera BJ. Isolation of seven respiratory viruses in shell vials: a practical and highly sensitive method. J. Clin. Microbiol. 31(2), 422-425 (1993).
42. La Scola B, Michel G, Raoult D. Isolation of Legionella pneumophila by centrifugation of shell vial cell cultures from multiple liver and lung abscesses. J. Clin. Microbiol. 37(3), 785-787 (1999).
43. Kim JS, Kim SH, Bae SY et al. Enhanced detection of respiratory viruses using cryopreserved R-Mix ready cells. J. Clin. Virol. 42(3), 264-267 (2008).
44. Thomas V, Herrera-Rimann K, Blanc DS, Greub G. Biodiversity of amoebae and amoeba-resisting bacteria in a hospital water network. Appl. Environ. Microbiol. 72(4), 2428-2438 (2006).
45. Visvesvara GS, Mirra SS, Brandt FH, Moss DM, Mathews HM, Martinez AJ. Isolation of two strains of Acanthamoeba castellanii from human tissue and their pathogenicity and isoenzyme profiles. J. Clin. Microbiol. 18(6), 1405-1412 (1983).
46. Molmeret M, Horn M, Wagner M, Santic M, Abu KY. Amoebae as training grounds for intracellular bacterial pathogens. Appl. Environ. Microbiol. 71(1), 20-28 (2005).
47. Greub G, Mege JL, Raoult D. Parachlamydia acanthamoebae enters and multiplies within human macrophages and induces their apoptosis [corrected]. Infect. Immun. 71(10), 5979-5985 (2003).
48. Casson N, Medico N, Bille J, Greub G. Parachlamydia acanthamoebae enters and multiplies within pneumocytes and lung fibroblasts. Microbes Infect. 8(5), 1294-1300 (2006).
49. Greub G. Parachlamydia acanthamoebae, an emerging agent of pneumonia. Clin. Microbiol. Infect. 15(1), 18-28 (2009).
50. La Scola B, Boyadjiev I, Greub G, Khamis A, Martin C, Raoult D. Amoeba-resisting bacteria and ventilator-associated pneumonia. Emerg. Infect. Dis. 9(7), 815-821 (2003).
51. La Scola B, Audic S, Robert C et al. A giant virus in amoebae. Science 299(5615), 2033 (2003).
52. Pagnier I, Raoult D, La Scola B. Isolation and identification of amoeba-resisting bacteria from water in human environment by using an Acanthamoeba polyphaga co-culture procedure. Environ. Microbiol. 10(5), 1135-1144 (2008).
53. Rowbotham TJ. Isolation of Legionella pneumophila from clinical specimens via amoebae, and the interaction of those and other isolates with amoebae. J. Clin. Pathol. 36(9), 978-986 (1983).
54. Greub G, La Scola B, Raoult D. Amoebae-resisting bacteria isolated from human nasal swabs by amoebal coculture. Emerg. Infect. Dis. 10(3), 470-477 (2004).
55. Evstigneeva A, Raoult D, Karpachevskiy L, La Scola B. Amoeba co-culture of soil specimens recovered 33 different bacteria, including four new species and Streptococcus pneumoniae. Microbiology 155(Pt 2), 657-664 (2009).
56. Fry NK, Rowbotham TJ, Saunders NA, Embley TM. Direct amplification and sequencing of the 16S ribosomal DNA of an intracellular Legionella species recovered by amoebal enrichment from the sputum of a patient with pneumonia. FEMS Microbiol. Lett. 67(2), 165-168 (1991).
57. La Scola B, Mezi L, Weiller PJ, Raoult D. Isolation of Legionella anisa using an amoebic coculture procedure. J. Clin. Microbiol. 39(1), 365-366 (2001).
58. Adekambi T, Reynaud-Gaubert M, Greub G et al. Amoebal coculture of 'Mycobacterium massiliense' sp. nov. from the sputum of a patient with hemoptoic pneumonia. J. Clin. Microbiol. 42(12), 5493-5501 (2004).
59. Seng P, Drancourt M, Gouriet F et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Infect. Dis. 49(4), 543-551 (2009).
60. Seng P, Rolain JM, Fournier PE, La Scola B, Drancourt M, Raoult D. MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol. 5(11), 1733-1754 (2010).
61. Williams TL, Andrzejewski D, Lay JO, Musser SM. Experimental factors affecting the quality and reproducibility of MALDI TOF mass spectra obtained from whole bacteria cells. J. Am. Soc. Mass Spectrom. 14(4), 342-351 (2003).
62. Drancourt M. Detection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a review. Clin. Microbiol. Infect. 16(11), 1620-1625 (2010).
63. La Scola B, Raoult D. Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry. PLoS ONE 4(11), e8041 (2009).
64. La Scola B. Intact cell MALDI-TOF mass spectrometry-based approaches for the diagnosis of bloodstream infections. Expert Rev. Mol. Diagn. 11(3), 287-298 (2011).
65. Ferreira L, Sanchez-Juanes F, Gonzalez-Avila M et al. Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 48(6), 2110-2115 (2010).
66. Köhling HL, Bittner A, Muller KD et al. Direct identification of bacteria in urine samples by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and relevance of defensins as interfering factors. J. Med. Microbiol. 61(Pt 3), 339-344 (2012).
67. Walker J, Fox AJ, Edwards-Jones V, Gordon DB. Intact cell mass spectrometry (ICMS) used to type methicillin-resistant Staphylococcus aureus: media effects and inter-laboratory reproducibility. J. Microbiol. Methods 48(2-3), 117-126 (2002).
68. Anderson KS, Ramachandran N, Wong J et al. Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J. Proteome Res. 7(4), 1490-1499 (2008).
69. Urbanowska T, Mangialaio S, Zickler C et al. Protein microarray platform for the multiplex analysis of biomarkers in human sera. J. Immunol. Methods 316(1-2), 1-7 (2006).
70. Gouriet F, Levy PY, Samson L, Drancourt M, Raoult D. Comparison of the new InoDiag automated fluorescence multiplexed antigen microarray to the reference technique in the serodiagnosis of atypical bacterial pneumonia. Clin. Microbiol. Infect. 14(12), 1119-1127 (2008).
71. Ardizzoni A, Capuccini B, Baschieri MC et al. A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections. Eur. J. Clin. Microbiol. Infect. Dis. 28(9), 1067-1075 (2009).
72. Mezzasoma L, Bacarese-Hamilton T, Di CM, Rossi R, Bistoni F, Crisanti A. Antigen microarrays for serodiagnosis of infectious diseases. Clin. Chem. 48(1), 121-130 (2002).
73. Jääskeläinen AJ, Moilanen K, Buhler S et al. Serological microarray for detection of HSV-1, HSV-2, VZV, and CMV antibodies. J. Virol. Methods 160(1-2), 167-171 (2009).
74. Bonhomme CJ, Renesto P, Nandi S, Lynn AM, Raoult D. Serological microarray for a paradoxical diagnostic of Whipple's disease. Eur. J. Clin. Microbiol. Infect. Dis. 27(10), 959-968 (2008).
75. Rucker VC, Havenstrite KL, Herr AE. Antibody microarrays for native toxin detection. Anal. Biochem. 339(2), 262-270 (2005).
76. Servoss SL, Gonzalez R, Varnum S, Zangar RC. High-throughput analysis of serum antigens using sandwich ELISAs on microarrays. Methods Mol. Biol. 520, 143-150 (2009).
77. Rao RS, Visuri SR, McBride MT, Albala JS, Matthews DL, Coleman MA. Comparison of multiplexed techniques for detection of bacterial and viral proteins. J. Proteome Res. 3(4), 736-742 (2004).
78. Kawanami T, Fukuda K, Yatera K, Kido M, Mukae H, Taniguchi H. A higher significance of anaerobes: the clone library analysis of bacterial pleurisy. Chest 139(3), 600-608 (2011).
79. Oosterheert JJ, van Loon AM, Schuurman R et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin. Infect. Dis. 41(10), 1438-1444 (2005).
80. Khot PD, Fredricks DN. PCR-based diagnosis of human fungal infections. Expert Rev. Anti Infect. Ther. 7(10), 1201-1221 (2009).
81. Harris KA, Hartley JC. Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology service. J. Med. Microbiol. 52(Pt 8), 685-691 (2003).
82. Chakravorty S, Helb D, Burday M, Connell N, Alland D. A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria. J. Microbiol. Methods 69(2), 330-339 (2007).
83. Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin. Microbiol. Infect. 14(10), 908-934 (2008).
84. Fontana C, Favaro M, Pelliccioni M, Pistoia ES, Favalli C. Use of the MicroSeq 500 16S rRNA gene-based sequencing for identification of bacterial isolates that commercial automated systems failed to identify correctly. J. Clin. Microbiol. 43(2), 615-619 (2005).
85. Zhou G, Cao B, Dou Y, Liu Y, Feng L, Wang L. PCR methods for the rapid detection and identification of four pathogenic Legionella spp. and two Legionella pneumophila subspecies based on the gene amplification of gyrB. Appl. Microbiol. Biotechnol. 91(3), 777-787 (2011).
86. Zong Z, Peng C, Lu X. Diversity of SCCmec elements in methicillin-resistant coagulase-negative staphylococci clinical isolates. PLoS ONE 6(5), e20191 (2011).
87. Park HK, Lee SJ, Yoon JW et al. Identification of the cpsA gene as a specific marker for the discrimination of Streptococcus pneumoniae from viridans group streptococci. J. Med. Microbiol. 59(Pt 10), 1146-1152 (2010).
88. Li W, Raoult D, Fournier PE. Bacterial strain typing in the genomic era. FEMS Microbiol. Rev. 33(5), 892-916 (2009).
89. Fluit AC, Visser MR, Schmitz FJ. Molecular detection of antimicrobial resistance. Clin. Microbiol. Rev. 14(4), 836-871 (2001).
90. Biere B, Schweiger B. Human adenoviruses in respiratory infections: sequencing of the hexon hypervariable region reveals high sequence variability. J. Clin. Virol. 47(4), 366-371 (2010).
91. Hilty M, Burke C, Pedro H et al. Disordered microbial communities in asthmatic airways. PLoS ONE 5(1), e8578 (2010).
92. Erb-Downward JR, Thompson DL, Han MK et al. Analysis of the lung microbiome in the 'healthy' smoker and in COPD. PLoS ONE 6(2), e16384 (2011).
93. Sze MA, Dimitriu PA, Hayashi S et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 185(10), 1073-1080 (2012).
94. Willner D, Haynes MR, Furlan M et al. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J. 6(2), 471-474 (2012).
95. Charlson ES, Bittinger K, Haas AR et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir. Crit. Care Med. 184(8), 957-963 (2011).
96. Delhaes L, Monchy S, Frealle E et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community - implications for therapeutic management. PLoS ONE 7(4), e36313 (2012).
97. Charlson ES, Diamond JM, Bittinger K et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am. J. Respir. Crit. Care Med. 186(6), 536-545 (2012).
98. Vandecandelaere I, Matthijs N, Van NF et al. Assessment of microbial diversity in biofilms recovered from endotracheal tubes using culture dependent and independent approaches. PLoS ONE 7(6), e38401 (2012).
99. Willner D, Furlan M, Haynes M et al. Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals. PLoS ONE 4(10), e7370 (2009).
100. Willner D, Haynes MR, Furlan M et al. Case studies of the spatial heterogeneity of DNA viruses in the cystic fibrosis lung. Am. J. Respir. Cell Mol. Biol. 46(2), 127-131 (2012).
101. Lysholm F, Wetterbom A, Lindau C et al. Characterization of the viral microbiome in patients with severe lower respiratory tract infections, using metagenomic sequencing. PLoS ONE 7(2), e30875 (2012).
102. Kunin V, Copeland A, Lapidus A, Mavromatis K, Hugenholtz P. A bioinformatician's guide to metagenomics. Microbiol. Mol. Biol. Rev. 72(4), 557-578, (2008).
103. Goddard AF, Staudinger BJ, Dowd SE et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc. Natl Acad. Sci. USA 109(34), 13769-13774 (2012).
104. Lin B, Vora GJ, Thach D et al. Use of oligonucleotide microarrays for rapid detection and serotyping of acute respiratory disease-associated adenoviruses. J. Clin. Microbiol. 42(7), 3232-3239 (2004).
105. Leinberger DM, Schumacher U, Autenrieth IB, Bachmann TT. Development of a DNA microarray for detection and identification of fungal pathogens involved in invasive mycoses. J. Clin. Microbiol. 43(10), 4943-4953 (2005).
106. Gardner SN, Jaing CJ, McLoughlin KS, Slezak TR. A microbial detection array (MDA) for viral and bacterial detection. BMC Genomics 11, 668 (2010).
107. Wilson KH, Wilson WJ, Radosevich JL et al. High-density microarray of small-subunit ribosomal DNA probes. Appl. Environ. Microbiol. 68(5), 2535-2541 (2002).
108. Volokhov DV, Kong H, Herold K, Chizhikov VE, Rasooly A. Oligonucleotide microarrays for identification of microbial pathogens and detection of their virulence-associated or drug-resistance determinants. Methods Mol. Biol. 671, 55-94 (2011).
109. Palacios G, Quan PL, Jabado OJ et al. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg. Infect. Dis. 13(1), 73-81 (2007).
110. Quan PL, Palacios G, Jabado OJ et al. Detection of respiratory viruses and subtype identification of influenza A viruses by GreeneChipResp oligonucleotide microarray. J. Clin. Microbiol. 45(8), 2359-2364 (2007).
111. Lin B, Malanoski AP, Wang Z et al. Application of broad-spectrum, sequence-based pathogen identification in an urban population. PLoS ONE 2(5), e419 (2007).
112. Huang YJ, Kim E, Cox MJ et al. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS 14(1), 9-59 (2010).
113. Wang D, Coscoy L, Zylberberg M et al. Microarray-based detection and genotyping of viral pathogens. Proc. Natl Acad. Sci. USA 99(24), 15687-15692 (2002).
114. Townsend MB, Dawson ED, Mehlmann M et al. Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillance. J. Clin. Microbiol. 44(8), 2863-2871 (2006).
115. Mehlmann M, Bonner AB, Williams JV et al. Comparison of the MChip to viral culture, reverse transcription-PCR, and the QuickVue influenza A+B test for rapid diagnosis of influenza. J. Clin. Microbiol. 45(4), 1234-1237 (2007).
116. Frobert E, Escuret V, Javouhey E et al. Respiratory viruses in children admitted to hospital intensive care units: evaluating the CLART® pneumovir DNA array. J. Med. Virol. 83(1), 150-155 (2011).
117. Burteau S, Bogaerts P, de MR et al. Design and validation of a low density array (Nosochip) for the detection and identification of the main pathogenic bacteria and fungi responsible for nosocomial pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 27(1), 17-27 (2008).
118. Anthony RM, Brown TJ, French GL. Rapid diagnosis of bacteremia by universal amplification of 23S ribosomal DNA followed by hybridization to an oligonucleotide array. J. Clin. Microbiol. 38(2), 781-788 (2000).
119. Chiu CY, Urisman A, Greenhow TL et al. Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children. J. Pediatr. 153(1), 76-83 (2008).
120. Auburn H, Zuckerman M, Broughton S, Greenough A, Smith M. Detection of nine respiratory RNA viruses using three multiplex RT-PCR assays incorporating a novel RNA internal control transcript. J. Virol. Methods 176(1-2), 9-13 (2011).
121. Khanna M, Fan J, Pehler-Harrington K et al. The pneumoplex assays, a multiplex PCR-enzyme hybridization assay that allows simultaneous detection of five organisms, Mycoplasma pneumoniae, Chlamydia (Chlamydophila) pneumoniae, Legionella pneumophila, Legionella micdadei, and Bordetella pertussis, and its real-time counterpart. J. Clin. Microbiol. 43(2), 565-571 (2005).
122. Osiowy C. Direct detection of respiratory syncytial virus, parainfluenza virus, and adenovirus in clinical respiratory specimens by a multiplex reverse transcription-PCR assay. J. Clin. Microbiol. 36(11), 3149-3154 (1998).
123. Abdeldaim GM, Stralin K, Korsgaard J, Blomberg J, Welinder-Olsson C, Herrmann B. Multiplex quantitative PCR for detection of lower respiratory tract infection and meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis. BMC Microbiol. 10, 310 (2010).
124. Rios-Licea MM, Bosques FJ, Arroliga AC, Galindo-Galindo JO, Garza-Gonzalez E. Quadruplex real-time quantitative PCR assay for the detection of pathogens related to late-onset ventilator-associated pneumonia: a preliminary report. J. Microbiol. Methods 81(3), 232-234 (2010).
125. Fujita SI, Senda Y, Nakaguchi S, Hashimoto T. Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains. J. Clin. Microbiol. 39(10), 3617-3622 (2001).
126. Stralin K, Korsgaard J, Olcen P. Evaluation of a multiplex PCR for bacterial pathogens applied to bronchoalveolar lavage. Eur. Respir. J. 28(3), 568-575 (2006).
127. Caliendo AM. Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin. Infect. Dis. 52(Suppl. 4), S326-S330 (2011).
128. Gharabaghi F, Hawan A, Drews SJ, Richardson SE. Evaluation of multiple commercial molecular and conventional diagnostic assays for the detection of respiratory viruses in children. Clin. Microbiol. Infect. 17(12), 1900-1906 (2011).
129. Harris KA, Turner P, Green EA, Hartley JC. Duplex real-time PCR assay for detection of Streptococcus pneumoniae in clinical samples and determination of penicillin susceptibility. J. Clin. Microbiol. 46(8), 2751-2758 (2008)
130. He J, Bose ME, Beck ET et al. Rapid multiplex reverse transcription-PCR typing of influenza A and B virus, and subtyping of influenza A virus into H1, 2, 3, 5, 7, 9, N1 (human), N1 (animal), N2, and N7, including typing of novel swine origin influenza A (H1N1) virus, during the 2009 outbreak in Milwaukee, Wisconsin. J. Clin. Microbiol. 47(9), 2772-2778 (2009).
131. Lehmann LE, Hunfeld KP, Emrich T et al. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med. Microbiol. Immunol. 197(3), 313-324 (2008).
132. Wallet F, Nseir S, Baumann L et al. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin. Microbiol. Infect. 16(6), 774-779 (2010).
133. Lehmann LE, Hauser S, Malinka T et al. Rapid qualitative urinary tract infection pathogen identification by SeptiFast real-time PCR. PLoS ONE 6(2), e17146 (2011).
134. Ali SA, Gern JE, Hartert TV et al. Real-world comparison of two molecular methods for detection of respiratory viruses. Virol. J. 8, 332 (2011).
135. Telfer S, Lambin X, Birtles R et al. Species interactions in a parasite community drive infection risk in a wildlife population. Science 330(6001), 243-246 (2010).
136. Varon E, Levy C, De La RF et al. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections. Clin. Infect. Dis. 31(2), 477-481 (2000).
137. Veenhoven R, Bogaert D, Uiterwaal C et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 361(9376), 2189-2195 (2003).
138. Pettigrew MM, Gent JF, Revai K, Patel JA, Chonmaitree T. Microbial interactions during upper respiratory tract infections. Emerg. Infect. Dis. 14(10), 1584-1591 (2008).
139. Adair CG, Gorman SP, Feron BM et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med. 25(10), 1072-1076 (1999).
140. Cvitkovitch DG, Li YH, Ellen RP. Quorum sensing and biofilm formation in Streptococcal infections. J. Clin. Invest. 112(11), 1626-1632 (2003).
141. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 284(5418), 1318-1322 (1999).
142. Kohler T, Guanella R, Carlet J, van DC. Quorum sensing-dependent virulence during Pseudomonas aeruginosa colonisation and pneumonia in mechanically ventilated patients. Thorax 65(8), 703-710 (2010).
143. Gorman SP, McGovern JG, Woolfson AD, Adair CG, Jones DS. The concomitant development of poly(vinyl chloride)-related biofilm and antimicrobial resistance in relation to ventilator-associated pneumonia. Biomaterials 22(20), 2741-2747 (2001).
144. Wise MP, Williams DW, Lewis MA, Frost PJ. Macrolides and community-acquired pneumonia: is quorum sensing the key? Crit. Care 14(4), 181 (2010).
145. Diaz MH, Shaver CM, King JD, Musunuri S, Kazzaz JA, Hauser AR. Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect. Immun. 76(10), 4414-4421 (2008).
146. Hoffman LR, Deziel E, D'Argenio DA et al. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 103(52), 19890-19895 (2006).
147. Roux D, Gaudry S, Dreyfuss D et al. Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Crit. Care Med. 37(3), 1062-1067 (2009).
148. Nseir S, Jozefowicz E, Cavestri B et al. Impact of antifungal treatment on Candida- Pseudomonas interaction: a preliminary retrospective case-control study. Intensive Care Med. 33(1), 137-142 (2007).
149. Neely AN, Law EJ, Holder IA. Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes. Infect. Immun. 52(1), 200-204 (1986).
150. Saijo T, Izumikawa K, Takazono T et al. A case of Legionella pneumophila pneumonia followed by invasive aspergillosis. Jpn J. Infect. Dis. 61(5), 379-381 (2008).
151. Avadhanula V, Rodriguez CA, Devincenzo JP et al. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J. Virol. 80(4), 1629-1636 (2006).
152. Pittet LA, Hall-Stoodley L, Rutkowski MR, Harmsen AG. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol. 42(4), 450-460 (2010).
153. Zavitz CC, Bauer CM, Gaschler GJ et al. Dysregulated macrophage- inflammatory protein-2 expression drives illness in bacterial superinfection of influenza. J. Immunol. 184(4), 2001-2013 (2010).
154. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J. Infect. Dis. 187(6), 1000-1009 (2003).
155. Rizzo C, Caporali MG, Rota MC. Pandemic influenza and pneumonia due to Legionella pneumophila: a frequently underestimated coinfection. Clin. Infect. Dis. 51(1), 115 (2010).
156. McNamara PS, Flanagan BF, Smyth RL, Hart CA. Impact of human metapneumovirus and respiratory syncytial virus co-infection in severe bronchiolitis. Pediatr. Pulmonol. 42(8), 740-743 (2007).
157. Greensill J, McNamara PS, Dove W, Flanagan B, Smyth RL, Hart CA. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg. Infect. Dis. 9(3), 372-375 (2003).
158. Semple MG, Cowell A, Dove W et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J. Infect. Dis. 191(3), 382-386 (2005).
159. Thorburn K, Harigopal S, Reddy V, Taylor N, van Saene HK. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 61(7), 611-615 (2006).
160. Delano MJ, Thayer T, Gabrilovich S et al. Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. J. Immunol. 186(1), 195-202 (2011).
161. Propst-Graham KL, Preheim LC, Vander Top EA, Snitily MU, Gentry-Nielsen MJ. Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae. BMC Microbiol. 7, 94 (2007).
162. Kerr J.R., Taylor GW, Rutman A, Hoiby N, Cole PJ, Wilson R. Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J. Clin. Pathol. 52(5), 385-387 (1999).
163. Regev-Yochay G, Trzcinski K, Thompson CM, Malley R, Lipsitch M. Interference between Streptococcus pneumoniae and Staphylococcus aureus: in vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J. Bacteriol. 188(13), 4996-5001 (2006).
164. Kreth J, Zhang Y, Herzberg MC. Streptococcal antagonism in oral biofilms: Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutans. J. Bacteriol. 190(13), 4632-4640 (2008).
165. Ocana VS, De Ruiz Holgado AA, Nader- Macias ME. Growth inhibition of Staphylococcus aureus by H2O2-producing Lactobacillus paracasei subsp. paracasei isolated from the human vagina. FEMS Immunol. Med. Microbiol. 23(2), 87-92 (1999).
166. Otero MC, Nader-Macias ME. Inhibition of Staphylococcus aureus by H2O2-producing Lactobacillus gasseri isolated from the vaginal tract of cattle. Anim. Reprod. Sci. 96(1-2), 35-46 (2006).
167. Mai-Prochnow A, Lucas-Elio P, Egan S et al. Hydrogen peroxide linked to lysine oxidase activity facilitates biofilm differentiation and dispersal in several Gram-negative bacteria. J. Bacteriol. 190(15), 5493-5501 (2008).
168. Margolis E. Hydrogen peroxide-mediated interference competition by Streptococcus pneumoniae has no significant effect on Staphylococcus aureus nasal colonization of neonatal rats. J. Bacteriol. 191(2), 571-575 (2009).
169. Peleg AY, Tampakakis E, Fuchs BB, Eliopoulos GM, Moellering RC Jr, Mylonakis E. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 105(38), 14585-14590 (2008).
170. Hogan DA, Kolter R. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296(5576), 2229-2232 (2002).
171. Hogan DA, Vik A, Kolter R. A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol. Microbiol. 54(5), 1212-1223 (2004).
172. Kerr Jr. Suppression of fungal growth exhibited by Pseudomonas aeruginosa. J. Clin. Microbiol. 32(2), 525-527 (1994).
173. Kaleli I, Cevahir N, Demir M, Yildirim U, Sahin R. Anticandidal activity of Pseudomonas aeruginosa strains isolated from clinical specimens. Mycoses 50(1), 74-78 (2007).
174. Ichinohe T, Pang IK, Kumamoto Y et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl Acad. Sci. USA 108(13), 5354-5359 (2011).
175. Laufer AS, Metlay JP, Gent JF, Fennie KP, Kong Y, Pettigrew MM. Microbial communities of the upper respiratory tract and otitis media in children. mBio 2(1), e00245-10 (2011).
176. Ayala VI, Teijaro JR, Farber DL, Dorsey SG, Carbonetti NH. Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity. PLoS ONE 6(4), e19016 (2011).
177. Hakansson A, Kidd A, Wadell G, Sabharwal H, Svanborg C. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect. Immun. 62(7), 2707-2714 (1994).
178. Golda A, Malek N, Dudek B et al. Infection with human coronavirus NL63 enhances streptococcal adherence to epithelial cells. J. Gen. Virol. 92(Pt 6), 1358-1368 (2011).
179. Teughels W, Sliepen I, Quirynen M et al. Human cytomegalovirus enhances A. actinomycetemcomitans adherence to cells. J. Dent. Res. 86(2), 175-180 (2007).
180. Rameix-Welti MA, Zarantonelli ML, Giorgini D et al. Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules. Infect. Immun. 77(9), 3588-3595 (2009).
181. Diavatopoulos DA, Short KR, Price JT et al. Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J. 24(6), 1789-1798 (2010).
182. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J. Infect. Dis. 186(3), 341-350 (2002).
183. Okamoto S, Kawabata S, Terao Y, Fujitaka H, Okuno Y, Hamada S. The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection. Infect. Immun. 72(10), 6068-6075 (2004).
184. Jones WT, Menna JH, Wennerstrom DE. Lethal synergism induced in mice by influenza type A virus and type Ia group B streptococci. Infect. Immun. 41(2), 618-623 (1983).
185. Passariello C, Nencioni L, Sgarbanti R et al. Viral hemagglutinin is involved in promoting the internalisation of Staphylococcus aureus into human pneumocytes during influenza A H1N1 virus infection. Int. J. Med. Microbiol. 301(2), 97-104 (2011).
186. Aebi T, Weisser M, Bucher E, Hirsch HH, Marsch S, Siegemund M. Co-infection of influenza B and Streptococci causing severe pneumonia and septic shock in healthy women. BMC Infect. Dis. 10, 308 (2010).
187. Kukavica-Ibrulj I, Hamelin ME, Prince GA et al. Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J. Virol. 83(3), 1341-1349 (2009).
188. Rubinas TC, Carey RB, Kampert MC, Alkan S, Lednicky JA. Fatal hemorrhagic pneumonia concomitant with Chlamydia pneumoniae and parainfluenza virus 4 infection. Arch. Pathol. Lab. Med. 128(6), 640-644 (2004).
189. Avadhanula V, Wang Y, Portner A, Adderson E. Nontypeable Haemophilus influenzae and Streptococcus pneumoniae bind respiratory syncytial virus glycoprotein. J. Med. Microbiol. 56(Pt 9), 1133-1137 (2007).
190. Jiang Z, Nagata N, Molina E, Bakaletz LO, Hawkins H, Patel JA. Fimbria-mediated enhanced attachment of nontypeable Haemophilus influenzae to respiratory syncytial virus-infected respiratory epithelial cells. Infect. Immun. 67(1), 187-192 (1999).
191. Van Ewijk BE, Wolfs TF, Aerts PC et al. RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells. Pediatr. Res. 61(4), 398-403 (2007).
192. Wilkinson TM, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 129(2), 317-324 (2006).
193. Ishizuka S, Yamaya M, Suzuki T et al. Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. J. Infect. Dis. 188(12), 1928-1939 (2003).
194. Passariello C, Schippa S, Conti C et al. Rhinoviruses promote internalisation of Staphylococcus aureus into non-fully permissive cultured pneumocytes. Microbes Infect. 8(3), 758-766 (2006).
195. Lysenko ES, Ratner AJ, Nelson AL, Weiser JN. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog. 1(1), e1 (2005).
196. Elahi S, Pang G, Ashman R, Clancy R. Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus. Clin. Exp. Immunol. 141(1), 29-36 (2005).
197. Machan ZA, Pitt TL, White W et al. Interaction between Pseudomonas aeruginosa and Staphylococcus aureus: description of an anti-staphylococcal substance. J. Med. Microbiol. 34(4), 213-217 (1991).
198. Qin Z, Yang L, Qu D, Molin S, Tolker- Nielsen T. Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiology 155(Pt 7), 2148-2156 (2009)
199. Kim Y, Mylonakis E. Killing of Candida albicans filaments by Salmonella enterica serovar Typhimurium is mediated by sopB effectors, parts of a type III secretion system. Eukaryot. Cell 10(6), 782-790 (2011).
200. Hechard Y, Ferraz S, Bruneteau E, Steinert M, Berjeaud JM. Isolation and characterization of a Staphylococcus warneri strain producing an anti-Legionella peptide. FEMS Microbiol. Lett. 252(1), 19-23 (2005).
201. Kerr Jr. Inhibition of growth of fungi pathogenic to man by Stenotrophomonas maltophilia. J. Med. Microbiol. 45(5), 380-382 (1996).
202. Tong H, Chen W, Shi W, Qi F, Dong X. SO-LAAO, a novel l-amino acid oxidase that enables Streptococcus oligofermentans to outcompete Streptococcus mutans by generating H2O2 from peptone. J. Bacteriol. 190(13), 4716-4721 (2008).
203. Wiley JA, Harmsen AG. Pneumocystis infection enhances antibody-mediated resistance to a subsequent influenza infection. J. Immunol. 180(8), 5613-5624 (2008).
204. Chen EC, Miller SA, DeRisi JL, Chiu CY. Using a pan-viral microarray assay (Virochip) to screen clinical samples for viral pathogens. J. Vis. Exp. (50), 2536 (2011). www.ncbi.nlm.nih.gov/pmc/articles/ PMC3169278